Mangalam Drugs and Organics Ltd
company logo

Mangalam Drugs and Organics Ltd

Pharmaceuticals
Small Cap

-

- (0%)


Mangalam Drugs and Organics Ltd Performance

-

-

-

-


-

-

-

-

-

Mangalam Drugs and Organics Ltd Fundamentals

169.60Cr

-

1.19

0.58

-

-%

89.93

i buttonClick here to know more about Fundamentals

Mangalam Drugs and Organics Ltd Financials

Mangalam Drugs and Organics Ltd Financialsright-arrow

Mangalam Drugs and Organics Ltd Shareholding Pattern

Mangalam Drugs and Organics Ltd Delivery and Volume

About Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a

Govardhan M Dhoot

1972

MANGALAM

NameDesignation
Govardhan M DhootChairman & Managing Director
Brijmohan DhootWhole-time Director
Rukmesh P. DhandhaniaIndependent Director
Nidhi S. MundadaIndependent Director
Praveen SaxenaIndependent Director
Jayant BardeCompany Sec. & Compli. Officer
Rakesh K. MilwaniDirector
News and Events...

Similar Stocks

What's Trending

Mangalam Drugs and Organics Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Mangalam Drugs and Organics Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Mangalam Drugs and Organics Ltd's share price is ₹109.43 as of 2024-07-15.
Mangalam Drugs and Organics Ltd's P/E ratio is - times as of 2024-07-15.
Mangalam Drugs and Organics Ltd's most recent financial reports indicate a price-to-book ratio of 1.19, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Mangalam Drugs and Organics Ltd's market capitalization is ₹169.6 Cr as on 2024-07-15.
The current financial records of Mangalam Drugs and Organics Ltd show a 0.84% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Mangalam Drugs and Organics Ltd's most recent financial filings, the company has a total asset value of ₹206.58, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Mangalam Drugs and Organics Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Mangalam Drugs and Organics Ltd's 52-week high and low as of 2024-07-15 are ₹109.99 and ₹106.53, respectively.